Search

BACKGROUND AND PURPOSE: The targeting of therapeutics is a promising approach for the development of new cancer treatments that seek to reduce the devastating side effects caused by the systemic administration of current drugs. This study evaluates a fusion protein developed as an enzyme prodrug therapy targeted to the tumor vasculature. Cytotoxicity would be localized to the site of the tumor using a protein fusion of purine nucleoside phosphorylase (PNP) and annexin V. Annexin V acts as the tumor-targeting component of the fusion protein as it has been shown to bind to phosphatidylserine expressed externally on cancer cells and the endothelial cells of the tumor vasculature, but not normal vascular endothelial cells. The enzymatic component of the fusion, PNP, converts the FDA-approved cancer therapeutic, fludarabine, into a more cytotoxic form. The purpose of this study is to determine if this system has a good potential as a targeted therapy for breast cancer. METHODS: A fusion of E. coli purine nucleoside phosphorylase and human annexin V was produced in E. coli and purified. Using human breast cancer cell lines MCF-7 and MDA-MB-231 and non-confluent human endothelial cells grown in vitro, the binding strength of the fusion protein and the cytotoxicity of the enzyme prodrug system were determined. Endothelial cells that are not confluent expose phosphatidylserine and therefore mimic the tumor vasculature. RESULTS: The purified recombinant fusion protein had good enzymatic activity and strong binding to the three cell lines. There was significant cell killing (p

Understanding the correlations between magnetic nanoparticles is important for nanotechnologies, such as high-density magnetic recording and biomedical applications, where functionalized magnetic particles are used as contrast agents and for drug delivery. The ability to control the magnetic state of individual particles depends on the good knowledge of the magnetic correlations between particles when assembled. Inaccessible via standard magnetometry techniques, nanoscale magnetic ordering in self-assemblies of Fe3O4 nanoparticles is here unveiled via X-ray resonant magnetic scattering (XRMS). Measured throughout the magnetization process, the XRMS signal reveals size-dependent inter-particle magnetic correlations. Smaller (5 nm) particles show little magnetic correlations, even when packed close together, yielding to magnetic disorder in the absence of an external field, i.e., superparamagnetism. In contrast, larger (11 nm) particles tend to be more strongly correlated, yielding a mix of magnetic orders including ferromagnetic and anti-ferromagnetic orders. These magnetic correlations are present even when the particles are sparsely distributed.

Semiconductor CdSe nanoparticles assemble into micrometer-sized spheres ranging from <1 to 50 μm when precipitated from hexane by methanol under conditions of stirring. Both solid and hollow spheres may be formed and the type of sphere can be controlled by the solvent concentration. In addition, stir rate and nanoparticle concentration influence sphere size. Redissolving the spheres back into a nonpolar solvent gives nanoparticles with their original absorption and photoluminescence properties. Precipitating nanoparticles from other nonpolar solvents such as toluene and chloroform does not result in sphere formation. [ABSTRACT FROM AUTHOR]

Bladder cancer has a 60%–70% recurrence rate most likely due to any residual tumour left behind after a transurethral resection (TUR). Failure to completely resect the cancer can lead to recurrence and progression into higher grade tumours with metastatic potential. We present here a novel therapy to treat superficial tumours with the potential to decrease recurrence. The therapy is a heat-based approach in which bladder tumour specific single-walled carbon nanotubes (SWCNTs) are delivered intravesically at a very low dose (0.1 mg SWCNT per kg body weight) followed 24 h later by a short 30 s treatment with a 360° near-infrared light that heats only the bound nanotubes. The energy density of the treatment was 50 J cm−2, and the power density that this treatment corresponds to is 1.7 W cm−2, which is relatively low. Nanotubes are specifically targeted to the tumour via the interaction of annexin V (AV) and phosphatidylserine, which is normally internalised on healthy tissue but externalised on tumours and the tumour vasculature. SWCNTs are conjugated to AV, which binds specifically to bladder cancer cells as confirmed in vitro and in vivo. Due to this specific localisation, NIR light can be used to heat the tumour while conserving the healthy bladder wall. In a short-term efficacy study in mice with orthotopic MB49 murine bladder tumours treated with the SWCNT-AV conjugate and NIR light, no tumours were visible on the bladder wall 24 h after NIR light treatment, and there was no damage to the bladder. In a separate survival study in mice with the same type of orthotopic tumours, there was a 50% cure rate at 116 days when the study was ended. At 116 days, no treatment toxicity was observed, and no nanotubes were detected in the clearance organs or bladder. [ABSTRACT FROM AUTHOR]

A new approach for targeting carbon nanotubes to the tumor vasculature was tested using human endothelial cells and MCF-7 breast cancer cells in vitro. Single-walled carbon nanotubes were functionalized with the F3 peptide using a polyethylene glycol linker to target nucleolin, a protein found on the surface of endothelial cells in the vasculature of solid tumors. Confocal microscopy and Raman analysis confirmed that the conjugate was internalized by actively dividing endothelial cells. Dividing endothelial cells were used to mimic these cells in the tumor vasculature. Incubation with the conjugate for 8 h or more caused significant cell death in both actively dividing endothelial cells and MCF-7 breast cancer cells, an effect that is hypothesized to be due to the massive uptake of the conjugate. This targeted cell killing was further enhanced when coupled with near-infrared laser treatment. For confluent (non-dividing) endothelial cells, no cytotoxic effect was seen for incubation alone or incubation coupled with laser treatment. These results are promising and warrant further studies using this conjugate for cancer treatment in vivo. [ABSTRACT FROM AUTHOR]

The objective of this study is to demonstrate the adsorption of horseradish peroxidase (HRP) on single-walled carbon nanotubes (SWNTs) using the sodium cholate suspension-dialysis method and to determine the effect of HRP adsorption on the biological activity of HRP and the UV-vis-NIR spectra of the SNWTs. The results indicate that this method results in a stable SWNT-protein suspension with complete retention of enzymatic activity of adsorbed HRP and also retention of a substantial fraction of the NIR absorption at 980 nm. The loading of protein on the SWNTs is high, and the overall yield of preparing the SWNT-protein suspension is also high. This process is promising for preparing SWNT-protein suspensions for biological applications where maintaining protein activity and SWNT absorption are important. [ABSTRACT FROM AUTHOR]

Abstract The greatest contributors to cancer mortality are metastasis and the consequences of its treatment. Here, we present a novel treatment of metastatic breast cancer that combines photothermal therapy with targeted single-walled carbon nanotubes (SWCNTs) and immunostimulation with a checkpoint inhibitor. We find that the selective near-infrared photothermal ablation of primary orthotopic EMT6 breast tumors in syngeneic BALB/cJ mice using an annexin A5 (ANXA5) functionalized SWCNT bioconjugate synergistically enhances an anti-cytotoxic T-lymphocyte-associated protein 4 (anti-CTLA-4)-dependent abscopal response, resulting in an increased survival (55%) at 100 days after tumor inoculation. In comparison, there was no survival at 100 days for either photothermal therapy by itself or immunostimulation by itself. Prior to photothermal therapy, the SWCNT-ANXA5 bioconjugate was administered systemically at a relatively low dose of 1.2 mg/kg, where it then accumulated in tumor vasculature via ANXA5-dependent binding. During photothermal therapy, the average maximum temperature in the tumor reached 54 °C (duration 175 s). The mechanism of prolonged survival resulting from combinatorial photothermal ablation and immune stimulation was evaluated by flow cytometric quantification of splenic antitumoral immune effector cells and serum cytokine quantification.